Global Information
회사소개 | 문의 | 위시리스트

세계의 바이오 의약품 분석 시험 서비스 시장(2018-2022년)

Global Biopharmaceutical Analytical Testing Services Market 2018-2022

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2018년 07월 상품 코드 672868
페이지 정보 영문 108 Pages
가격
US $ 2,500 ₩ 2,987,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,584,000 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,779,000 PDF by E-mail (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,974,000 PDF by E-mail (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 바이오 의약품 분석 시험 서비스 시장(2018-2022년) Global Biopharmaceutical Analytical Testing Services Market 2018-2022
발행일 : 2018년 07월 페이지 정보 : 영문 108 Pages

바이오 의약품 분석 시험 서비스에 대해

분석 시험 서비스는 바이오 의약품 개발과 제조의 모든 단계에서 중요한 부분입니다. 검증된 분석 시험 서비스로부터 얻은 정량적 및 정성적 결과는 원재료, 중간체 및 완성품의 규제 기준을 관리 및 보증하기 위한 정보를 제공하고 있습니다.

Technavio의 애널리스트는 2018-2022년간 세계의 바이오 의약품 분석 시험 서비스 시장이 8.98%의 연평균 성장률(CAGR)로 성장할 것으로 예측했습니다.

세계의 바이오 의약품 분석 시험 서비스(Biopharmaceutical Analytical Testing Services) 시장에 대해 조사 분석했으며, 시장 규모와 성장률, 시장 동향, 시장 성장 촉진요인과 과제, 시장 기회, 주요 벤더 등의 정보를 전해드립니다.

목차

제1장 주요 요약

제2장 조사 범위

제3장 조사 방법

제4장 시장 상황

  • 시장 생태계
  • 시장 특성
  • 시장 세분화 분석

제5장 시장 규모

  • 시장 정의
  • 시장 규모(2017년)
  • 시장 규모 및 예측(2017-2022년)

제6장 Five Forces 분석

  • 구매자의 협상력
  • 공급업체의 협상력
  • 신규 참여업체의 위협
  • 대체품의 위협
  • 경쟁사의 위협
  • 시장 상황

제7장 고객 상황

제8장 시장 세분화 : 최종사용자별

  • 세분화 : 최종사용자별(2017-2022년)
  • 비교 : 최종사용자별
  • 제약 및 바이오테크놀러지 기업
  • CRO
  • 시장 기회 : 최종사용자별

제9장 지역 상황

  • 지역별 세분화(2017-2022년)
  • 지역 비교
  • 아메리카
  • 유럽, 중동 및 아프리카
  • 아시아태평양
  • 시장 기회

제10장 의사결정 체계

제11장 성장 촉진요인과 과제

  • 시장 성장 촉진요인
  • 시장 과제

제12장 시장 동향

  • R&D 투자의 증가
  • 백신 생산의 증가
  • 분석 시험 서비스의 아웃소싱 확대

제13장 벤더 상황

  • 개요
  • 창조적 파괴 상황

제14장 벤더 분석

  • 대상 벤더
  • 벤더 분류
  • 벤더의 시장 포지셔닝
  • Catalent
  • Charles River
  • Eurofins Scientific
  • Merck KGaA
  • SGS

제15장 부록

  • 약어 리스트
KSM 18.08.17

About Biopharmaceutical Analytical Testing Services

Analytical testing services are a critical part of all steps in biopharmaceutical development and manufacturing. The quantitative and qualitative results produced from validated analytical testing services provide information to control and ensure the regulatory standard of raw materials, intermediaries, and finished products.

Technavio's analysts forecast the global biopharmaceutical analytical testing services market to grow at a CAGR of 8.98% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global biopharmaceutical analytical testing services market for 2018-2022. To calculate the market size, the report considers the revenue generated from the analytical testing services for biopharmaceutical and biotechnology companies, and contract research organizations (CROs).

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Biopharmaceutical Analytical Testing Services Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Catalent
  • Charles River
  • Eurofins Scientific
  • Merck KGaA
  • SGS

Market driver

  • Increase in demand for mAbs
  • For a full, detailed list, view our report

Market challenge

  • Shortage of trained professionals
  • For a full, detailed list, view our report

Market trend

  • Rise in production of vaccines
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER

  • Segmentation by end-user
  • Comparison by end-user
  • Pharmaceutical and biotechnology companies - Market size and forecast 2017-2022
  • CROs - Market size and forecast 2017-2022
  • Market opportunity by end-user

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Rise in investment in R&D
  • Rise in production of vaccines
  • Increasing outsourcing of analytical testing services

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Catalent
  • Charles River
  • Eurofins Scientific
  • Merck KGaA
  • SGS

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Related market
  • Exhibit 02: Market characteristics
  • Exhibit 03: Market segments
  • Exhibit 04: Market definition - Inclusions and exclusions checklist
  • Exhibit 05: Market size 2017
  • Exhibit 06: Validation techniques employed for market sizing 2017
  • Exhibit 07: Global biopharmaceutical analytical testing services market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 08: Global biopharmaceutical analytical testing services market - Year-over-year growth 2018-2022 (%)
  • Exhibit 09: Five forces analysis 2017
  • Exhibit 10: Five forces analysis 2022
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2017
  • Exhibit 17: Customer landscape
  • Exhibit 18: End-user - Market share 2017-2022 (%)
  • Exhibit 19: Comparison by end-user
  • Exhibit 20: Pharmaceutical and biotechnology companies - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Pharmaceutical and biotechnology companies - Year-over-year growth 2018-2022 (%)
  • Exhibit 22: CROs - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: CROs - Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Market opportunity by end-user
  • Exhibit 25: Global biopharmaceutical analytical testing services market - Market share by geography 2017-2022 (%)
  • Exhibit 26: Regional comparison
  • Exhibit 27: Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 28: Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 29: Top 3 countries in Americas
  • Exhibit 30: EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 31: EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 32: Top 3 countries in EMEA
  • Exhibit 33: APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 34: APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 35: Top 3 countries in APAC
  • Exhibit 36: Market opportunity
  • Exhibit 37: Some therapeutic applications of mAbs
  • Exhibit 38: Exhibit 18: List of bioterrorism agents and their threat category
  • Exhibit 39: Vendor landscape
  • Exhibit 40: Landscape disruption
  • Exhibit 41: Vendors covered
  • Exhibit 42: Vendor classification
  • Exhibit 43: Market positioning of vendors
  • Exhibit 44: Catalent overview
  • Exhibit 45: Catalent - Business segments
  • Exhibit 46: Catalent - Organizational developments
  • Exhibit 47: Catalent - Geographic focus
  • Exhibit 48: Catalent - Segment focus
  • Exhibit 49: Catalent - Key offerings
  • Exhibit 50: Vendor overview
  • Exhibit 51: Charles River - Business segments
  • Exhibit 52: Charles River - Organizational developments
  • Exhibit 53: Charles River - Geographic focus
  • Exhibit 54: Charles River - Segment focus
  • Exhibit 55: Charles River - Key offerings
  • Exhibit 56: Eurofins Scientific overview
  • Exhibit 57: Eurofins Scientific - Business segments
  • Exhibit 58: Eurofins Scientific - Organizational developments
  • Exhibit 59: Eurofins Scientific - Geographic focus
  • Exhibit 60: Eurofins Scientific - Segment focus
  • Exhibit 61: Eurofins Scientific - Key offerings
  • Exhibit 62: Merck KGaA overview
  • Exhibit 63: Merck KGaA - Business segments
  • Exhibit 64: Merck KGaA - Organizational developments
  • Exhibit 65: Merck KGaA - Geographic focus
  • Exhibit 66: Merck KGaA - Segment focus
  • Exhibit 67: Merck KGaA - Key offerings
  • Exhibit 68: SGS overview
  • Exhibit 69: SGS - Business segments
  • Exhibit 70: SGS - Organizational developments
  • Exhibit 71: SGS - Geographic focus
  • Exhibit 72: SGS - Segment focus
  • Exhibit 73: SGS - Key offerings
Back to Top
전화 문의
F A Q